Inventor · disambiguated record
Christopher T. Clark
Also filed as: CLARK CHRISTOPHER T
18 granted patents·11 pending applications·84 citations·filing 2007–2025
93Inventor score
Files withGILEAD SCIENCES INC22ARRAY BIOPHARMA INC4BURGESS LAURENCE E1CLARK CHRISTOPHER T1COOK ADAM1
Top patents by PatentIndex Score
29 records- 0197US11905299B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 20, 2024·3 cites·3 claims
- 0296US11066414B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Granted Jul 20, 2021·10 cites·9 claims
- 0395US9878995B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jan 30, 2018·14 cites·16 claims
- 0494US11224600B2Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Jan 18, 2022·9 cites·21 claims
- 0592US10316017B2COT modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 11, 2019·12 cites·30 claims
- 0692US9815818B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Granted Nov 14, 2017·13 cites·32 claims
- 0789US11179383B2Compounds for inhibition of α4β7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·3 cites·20 claims
- 0885US2025346609A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 0985US2024254137A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1083US11174256B2Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 16, 2021·2 cites·18 claims
- 1183US11116760B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2019·Granted Sep 14, 2021·3 cites·23 claims
- 1279US11578069B2Compounds for inhibition of α4 β7 integrinGILEAD SCIENCES INC·Filed 2020·Granted Feb 14, 2023·1 cites·11 claims
- 1378US8716498B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2013·Granted May 6, 2014·2 cites·1 claims
- 1477US2025032473A1Quinoline derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1576US9096567B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Aug 4, 2015·2 cites·31 claims
- 1676US8569522B26-substituted phenoxychroman carboxylic acid derivativesBURGESS LAURENCE E·Filed 2009·Granted Oct 29, 2013·3 cites·37 claims
- 1774US8785445B27-phenoxychroman carboxylic acid derivativesCOOK ADAM·Filed 2009·Granted Jul 22, 2014·4 cites·14 claims
- 1874US8026233B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 1972US9556139B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2015·Granted Jan 31, 2017·1 cites·14 claims
- 2069US2019248807A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2168US12053462B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2021·Granted Aug 6, 2024·0 cites·18 claims
- 2266US2018237455A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2365US2025051309A1Mk2 inhibitors and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2465US2022226337A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2565US2022152014A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2664US12410160B2KHK inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Sep 9, 2025·0 cites·38 claims
- 2763US2022135561A1Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2861US2017008905A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 2939US2012065195A1Compounds for treating neurodegenerative diseasesCLARK CHRISTOPHER T·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher T. Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →